We have previously demonstrated that TGF-β induces EMT in A549 lung adenocarcinoma cells [16], which harbor an activating K-ras mutation and form a tumor with well-differentiated adenocarcinoma histology when subcutaneously injected into immunocompromized mice [17], [18]. This evidence concerns the gene TGFB1 and lung adenocarcinoma.